MarketAxess heads into its August 5 earnings date under coordinated analyst pressure — targets have been slashed across the Street this week even as short sellers quietly trim the positions they rebuilt just days ago.
The analyst story is the dominant feature right now. Since the July 8 note, the cuts have accelerated. Morgan Stanley lowered its target to $129 from $195 on July 10, and Piper Sandler followed on July 15 with a cut to $128 from $175 — both maintaining neutral-equivalent ratings rather than pressing a directional call. Goldman Sachs had already moved to $130 from $168 at end of June. The one outlier is UBS, which held a Buy rating while trimming to $200 from $215. The consensus mean target has settled at $158, still well above the $114.87 close, but the direction of travel is unmistakably downward. The bear case is concrete: EPS guidance was cut for 2025 and 2026, April credit fee-per-million came in at $139 against an estimated $146, and market share concerns in core credit are growing. Bulls point to the electronification secular tailwind and newer initiatives — X-Pro, Adaptive Auto-X, the block trading launch — as reasons to hold on, but those arguments haven't stopped the target resets.
Short interest tells a modestly different story from a week ago. The previous note flagged a sharp rebuild to 6.6% of float by July 7. That position has since unwound slightly: SI dropped 5.2% over the past week to 6.3% of float, with shares short back near 2.33 million after peaking around 2.50 million on July 8. The unwind is modest, not a capitulation. Borrow conditions remain frictionless — availability runs at roughly 1,430%, meaning there are more than 14 shares available to lend for every one currently borrowed, and cost to borrow, while up 72% on the week to 0.67%, is still objectively low. The ORTEX short score has eased to 45.9 from 47.1 a week ago, consistent with a small covering move rather than a trend reversal. The stock itself is down 3.1% on the week to $114.87, off about 5% for the month — so shorts who rebuilt into early July have made money, but the positions aren't being pressed aggressively from here.
Options positioning has nudged more cautious without becoming alarming. The put/call ratio moved to 0.059, roughly 1.6 standard deviations above its 20-day average of 0.051. That's elevated but not extreme — the 52-week high on this metric is 0.67, so the current reading is closer to baseline than to a genuine defensive extreme. Valuation multiples have compressed with the stock: the P/E has fallen about 2.8 points over 30 days to 13.3x, and price-to-book is down 0.6x to 3.0x. Neither reads as cheap enough to provide a floor argument on its own, particularly with forward earnings estimates still moving lower per the factor scores — EPS momentum over 90 days ranks in just the 25th percentile, and the 12-month forward earnings growth rank sits at the 10th.
The institutional picture is steady rather than panicked. BlackRock added 329,000 shares in the period ended June 30, bringing its stake to 11.5%. Neuberger Berman added 416,000 shares in the same period. Those are meaningful additions against a backdrop of a falling stock and an analyst community cutting targets, and they provide some counterweight to the bearish narrative. Insider activity has been limited to small, routine sells — the General Counsel has sold 100 shares monthly like clockwork, and a June CFO sale was under $41,000. Nothing in the insider log suggests conviction in either direction from management.
Closest peers TW and CME both outperformed MKTX on the week — TW fell 1.4% while CME rose 1.2%, against MKTX's 3.1% decline. NDAQ gained 1.8%. The underperformance is notable and consistent with the stock-specific pressure from the guidance cut and target resets rather than sector-wide weakness. What to watch into the August 5 print is whether the credit fee-per-million trajectory stabilises, and whether the block trading initiative shows measurable share gains — those are the two metrics the Street trimmed around, and they'll set the tone for how the post-earnings positioning unfolds.
See the live data behind this article on ORTEX.
Open MKTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
